Lv4
410 积分 2024-09-11 加入
Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial
1天前
已完结
Liver function effects of SGLT2 inhibitor and GLP‐1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study)
3天前
已关闭
One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA
3天前
已完结
SGLT2 inhibitor plus DPP‐4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta‐analysis
8天前
已完结
Genitourinary Tract Infections in Patients Taking SGLT2 Inhibitors
8天前
已完结
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
15天前
已完结
Common mistakes concerning diabetes management in daily clinical practice
1个月前
已关闭
Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications
1个月前
已完结
Exploring, tailoring, and traversing the solution landscape of a phase-shaped CARS process
1个月前
已关闭
Fasting and postprandial plasma glucose contributions to hemoglobin A1c and time in range in people with diabetes on multiple daily injection insulin therapy: Results from the PRONTO-T1D and PRONTO-T2D clinical trials
1个月前
已完结
皖公网安备34019202002308
